INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
BM
Corporate insider

Benkowitz Michael

PRESIDENT AND COOCIK 0001673232

EDGAR filingsOpen in network
Disclosed transactions34
Buys / sells0 / 20
Max Insider Score34
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
28
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$6,591
14 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    UNITED THERAPEUTICS CorpPRESIDENT AND COO · Dec 30, 2025
24
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL
$6.90M
14.6K sh
Jan 26, 2026
Jan 28, 2026
traded Jan 26, 2026
+2d
SEC FORM 4

Evidence

1
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.15M
7,875 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

24
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$3.72M
7,875 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

13
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

0
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

14
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.15M
7,875 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$125K
271 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

30
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$612K
1,322 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$170K
372 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

23
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$173K
377 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$123K
268 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

0
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

16
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$29K
63 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

30
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$568K
1,225 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

30
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$449K
966 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

26
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$265K
568 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

23
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$150K
321 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

34
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$736K
1,573 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

31
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$212K
451 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

28
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$40K
84 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC FORM 4

Evidence

1
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.72M
14.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC FORM 4

Evidence

27
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$3.78M
7,875 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

3
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
14.6K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

3
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

27
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$7.01M
14.6K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

4
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.72M
14.6K sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

4
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.15M
7,875 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

3
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
7,875 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

8
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.72M
14.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

3
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M—
14.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

8
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Option exercise · 10b5-1 plan
M$1.15M
7,875 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

31
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$3.96M
7,875 sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence

31
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$7.35M
14.6K sh
Dec 29, 2025Dec 30, 2025
traded Dec 29, 2025
+1dSEC FORM 4

Evidence